- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
VOCFOR Report 4 - Ho Chi Minh City Rehabilitation and Occupational Treatment Hospital
On the afternoon of June 5, 2019, a regular Scientific and Technical meeting of the Medicine and Treatment Council of Ho Chi Minh City Occupational Rehabilitation and Treatment Hospital (313 Au Duong Lan, District 8, City) took place. .HCM). CPDP Medbolide Company participated in introducing VOCFOR 4 product with the topic "Lornoxicam - Effective anti-inflammatory pain relief solution". Attending the event was the Director of the Hospital - BSCKII. Nguyen Hoai Nam - with 15 Doctors of the Hospital Medicine and Treatment Council.
Here, representatives of Medbolide Company reported and discussed in more depth with doctors about the anti-inflammatory mechanism and safety of minimizing side effects of Lornoxicam, as well as the competitive advantages of VOCFOR compared to other products. the same group.
At the end of the report, the representative of Medbolide Company thanked the doctors and pledged to continue efforts to create quality medicinal products to serve public health.
Readers comments